Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Virtual clinical trials via a QSP immuno-oncology model to simulate the response to a conditionally activated PD-L1 targeting antibody in NSCLC

    Recently, immunotherapies for antitumoral response have adopted conditionally activated molecules with the objective of reducing systemic toxicity. Amongst these are conditionally activated antibodies, such as...

    Alberto Ippolito, Hanwen Wang, Yu Zhang in Journal of Pharmacokinetics and Pharmacody… (2024)

  2. Article

    Open Access

    Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth

    Chemokinostatin-1 (CKS1) is a 24-mer peptide originally discovered as an anti-angiogenic peptide derived from the CXCL1 chemokine. Here, we demonstrate that CKS1 acts not only as an anti-angiogenic peptide but...

    Natsuki Furukawa, Wendy Yang, Alex R. Chao, Akash Patil in Cell Death Discovery (2024)

  3. Article

    Open Access

    Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells

    Inflammatory cytokine mediated responses are important in the development of many diseases that are associated with angiogenesis. Targeting angiogenesis as a prominent strategy has shown limited effects in man...

    Min Song, Youli Wang, Brian H. Annex in npj Systems Biology and Applications (2023)

  4. Article

    Open Access

    Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence

    Novel immunotherapy combination therapies have improved outcomes for patients with hepatocellular carcinoma (HCC), but responses are limited to a subset of patients. Little is known about the inter- and intra-...

    Shuming Zhang, Long Yuan, Ludmila Danilova, Guanglan Mo, Qingfeng Zhu in Genome Medicine (2023)

  5. Article

    Open Access

    Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition

    Generating realistic virtual patients from a limited amount of patient data is one of the major challenges for quantitative systems pharmacology modeling in immuno-oncology. Quantitative systems pharmacology (...

    Hanwen Wang, Theinmozhi Arulraj, Holly Kimko, Aleksander S. Popel in npj Precision Oncology (2023)

  6. Article

    Open Access

    A systems biology model of junctional localization and downstream signaling of the Ang–Tie signaling pathway

    The Ang–Tie signaling pathway is an important vascular signaling pathway regulating vascular growth and stability. Dysregulation in the pathway is associated with vascular dysfunction and numerous diseases tha...

    Yu Zhang, Christopher D. Kontos, Brian H. Annex in npj Systems Biology and Applications (2021)

  7. Article

    Open Access

    A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor

    Cancer immunotherapy has recently drawn remarkable attention as promising results in the clinic have shown its ability to improve the overall survival, and T cells are considered to be one of the primary effec...

    Huilin Ma, Hanwen Wang, Richard J. Sove, Mohammad Jafarnejad in The AAPS Journal (2020)

  8. Article

    Open Access

    Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

    Hepatocyte growth factor (HGF) signaling through its receptor Met has been implicated in hepatocellular carcinoma tumorigenesis and progression. Met interaction with integrins is shown to modulate the downstre...

    Mohammad Jafarnejad, Richard J. Sové in npj Systems Biology and Applications (2019)

  9. Article

    Open Access

    A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade

    Over the past decade, several immunotherapies have been approved for the treatment of melanoma. The most prominent of these are the immune checkpoint inhibitors, which are antibodies that block the inhibitory ...

    Oleg Milberg, Chang Gong, Mohammad Jafarnejad, Imke H. Bartelink in Scientific Reports (2019)

  10. Article

    Open Access

    A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer

    Immunotherapy and immune checkpoint blocking antibodies such as anti-PD-1 are approved and significantly improve the survival of advanced non-small cell lung cancer (NSCLC) patients, but there has been little ...

    Mohammad Jafarnejad, Chang Gong, Edward Gabrielson, Imke H. Bartelink in The AAPS Journal (2019)

  11. Article

    Open Access

    Tumor Ensemble-Based Modeling and Visualization of Emergent Angiogenic Heterogeneity in Breast Cancer

    There is a critical need for new tools to investigate the spatio-temporal heterogeneity and phenotypic alterations that arise in the tumor microenvironment. However, computational investigations of emergent in...

    Spyros K. Stamatelos, Akanksha Bhargava, Eugene Kim in Scientific Reports (2019)

  12. Article

    Open Access

    Author Correction: Deciphering microvascular changes after myocardial infarction through 3D fully automated image analysis

    A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

    Polyxeni Gkontra, Kerri-Ann Norton, Magdalena M. Żak in Scientific Reports (2018)

  13. Article

    Open Access

    Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

    Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and incurable disease. Numerous studies have been conducted to seek molecular targets to treat TNBC effectively, but chemotherapy is still the...

    Kideok **, Niranjan B. Pandey, Aleksander S. Popel in Breast Cancer Research (2018)

  14. Article

    Open Access

    Deciphering microvascular changes after myocardial infarction through 3D fully automated image analysis

    The microvasculature continuously adapts in response to pathophysiological conditions to meet tissue demands. Quantitative assessment of the dynamic changes in the coronary microvasculature is therefore crucia...

    Polyxeni Gkontra, Kerri-Ann Norton, Magdalena M. Żak in Scientific Reports (2018)

  15. Article

    Open Access

    An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia

    Triple-negative breast cancer lacks estrogen, progesterone, and HER2 receptors and is thus not possible to treat with targeted therapies for these receptors. Therefore, a greater understanding of triple-negati...

    Kerri-Ann Norton, Travis Wallace, Niranjan B. Pandey in BMC Systems Biology (2017)

  16. Article

    Open Access

    The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts

    The plasticity of cancer cells and the fluidity of the tumor microenvironment continue to present major challenges in the comprehensive understanding of cancer that is essential to design effective treatments....

    Louis Dore-Savard, Esak Lee, Samata Kakkad, Aleksander S. Popel in Scientific Reports (2016)

  17. Article

    Open Access

    A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouse

    Angiogenesis is the growth of new blood vessels from pre-existing microvessels. Peripheral arterial disease (PAD) is caused by atherosclerosis that results in ischemia mostly in the lower extremities. Clinical...

    Liang-Hui Chu, Vijay Chaitanya Ganta, Min H. Choi, George Chen in Scientific Reports (2016)

  18. Article

    Open Access

    Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis

    Angiogenesis, the recruitment of new blood vessels, is a critical process for the growth, expansion, and metastatic dissemination of develo** tumors. Three types of cells make up the new vasculature: tip cel...

    Kerri-Ann Norton, Aleksander S. Popel in Scientific Reports (2016)

  19. No Access

    Article

    Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success

    Hierarchical processes spanning several orders of magnitude of both space and time underlie nearly all cancers. Multi-scale statistical, mathematical, and computational modeling methods are central to designin...

    Thomas E. Yankeelov, Gary An, Oliver Saut in Annals of Biomedical Engineering (2016)

  20. No Access

    Article

    Multiscale Modeling in the Clinic: Drug Design and Development

    A wide range of length and time scales are relevant to pharmacology, especially in drug development, drug design and drug delivery. Therefore, multiscale computational modeling and simulation methods and parad...

    Colleen E. Clancy, Gary An, William R. Cannon in Annals of Biomedical Engineering (2016)

previous disabled Page of 3